$THC is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 6 active Congressional signals mentioning $THC, including 6 bills. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.
The FAIR Act (HR2314) is an early-stage reporting bill with negligible near-term market impact. It requires hospitals with residency programs to report osteopathic vs. allopathic applicant data to HHS or face a 2% Medicare payment penalty. No funding is authorized. The bill is in committee with 16 cosponsors. Real market data shows hospital stocks (HCA, UHS, THC) falling 6-10% in the last 30 days, driven by broader market forces, not this bill.
HR5283 recaptures 40,000 unused immigrant visas for nurses and physicians — a long-term labor supply fix for hospitals, not an immediate spending catalyst. At an early committee stage with 12 cosponsors, passage is uncertain. Real market data shows hospital stocks in a broad 30-day decline of -7% to -12%, driven by macro factors unrelated to this bill.
HR3415 mandates federal hospital nurse-to-patient ratios, imposing significant new labor costs on hospital operators ($HCA, $UHS, $THC, $CYH) while creating a structural tailwind for healthcare staffing firms ($AMN, $RHI). The bill has 40 cosponsors and a Senate companion, signaling meaningful advancement probability despite early legislative stage. Real market data confirms the trend: hospital stocks have declined 2-8% in 30 days, staffing firms have risen 5-14%.
The Second Chances for Rural Hospitals Act (HR1775) is an early-stage bill that would expand REH eligibility to hospitals that closed between 2014-2020. This is a procedural matter with no near-term market impact — the bill has been referred to two committees and faces a long legislative path. Major hospital operators HCA, UHS, and THC would see modest upside if the bill passes, but current stock movements reflect broader market dynamics, not legislative catalysts.
The Emergency Care Improvement Act (HR3134) would expand Medicare and Medicaid reimbursement to freestanding emergency centers (FECs), directly benefiting operators like Tenet Healthcare ($THC) and HCA Healthcare ($HCA) with new revenue streams. The bill is in early legislative stages (referred to committee May 2025), but the 14 cosponsors and Texas-centric sponsorship signal regional momentum. Both $THC and $HCA have seen recent price declines — $THC down 4.37% and $HCA down 8.28% in the last 7 days — with no connection to this early-stage bill.
H.R. 6804 (Rural Hospital Flexibility Act of 2025) is an early-stage authorization bill that expands eligible uses for existing Medicare rural hospital flexibility grants. No specific funding is appropriated. The bill has been referred to the House Ways and Means Committee with only 4 total sponsors. Market impact is negligible; the legislative path is long and uncertain.